UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 721

Sortiert nach

Mucinous epithelial ovarian carcinoma

Annals of oncology, 2016-04, Vol.27 Suppl 1 (suppl_1), p.i53-i57

Perren, T J

2016

Volltextzugriff (PDF)

Clinical utility of complex multi-platform profiling in metastatic cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii480-viii480

2018

Volltextzugriff (PDF)

Feasibility and Compliance of Automated Measurement of Quality of Life in Oncology Practice

Journal of clinical oncology, 2003-01, Vol.21 (2), p.374-382

2003

Volltextzugriff (PDF)

Women with peritoneal carcinomatosis of unknown origin: efficacy of image‐guided biopsy to determine site‐specific diagnosis

BJOG : an international journal of obstetrics and gynaecology, 2007-01, Vol.114 (1), p.46-50

2007

Volltextzugriff (PDF)

Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study

British journal of cancer, 2004-08, Vol.91 (4), p.621-626

2004

Volltextzugriff (PDF)

Vascular endothelial growth factor (VEGF) in breast cancer : Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen

Cancer research (Chicago, Ill.), 2000-06, Vol.60 (11), p.2898-2905

2000

Volltextzugriff (PDF)

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial

Annals of oncology, 2004-05, Vol.15 (5), p.751-758

2004

Volltextzugriff (PDF)

Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: The ITS Study

British journal of cancer, 2008-01, Vol.98 (1), p.39-44

2008

Volltextzugriff (PDF)

Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies

British journal of cancer, 1993-07, Vol.68 (1), p.122-124

1993

Volltextzugriff (PDF)

Clinical outcomes according to age and comorbidities in the OSCAR UK observational study of front-line bevacizumab (BEV)-containing therapy for advanced ovarian cancer (aOC)

Annals of oncology, 2018-10, Vol.29, p.viii350-viii351

2018

Volltextzugriff (PDF)

Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation

British journal of cancer, 2003-05, Vol.88 (10), p.1578-1583

2003

Volltextzugriff (PDF)

c-erbB-2 oncogene as a prognostic marker in breast cancer

British journal of cancer, 1991-03, Vol.63 (3), p.328-332

PERREN, T. J

1991

Volltextzugriff (PDF)

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment

Annals of oncology, 2018-10, Vol.29, p.viii336-viii336

2018

Volltextzugriff (PDF)

Detection of colorectal cancer cells in peripheral blood by reverse‐transcriptase polymerase chain reaction for cytokeratin 20

International journal of cancer, 1998-06, Vol.79 (3), p.288-293

1998

Volltextzugriff (PDF)

Peritoneal carcinomatosis: image-guided peritoneal core biopsy for tumor type and patient care

Radiology, 2001-10, Vol.221 (1), p.173

2001

Volltextzugriff (PDF)

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

ESMO open, 2021-04, Vol.6 (2), p.100043-100043, Article 100043

2021

Volltextzugriff (PDF)

The acute phase protein response in patients receiving subcutaneous IL‐6

Clinical and experimental immunology, 1995-10, Vol.102 (1), p.217-223

1995

Volltextzugriff (PDF)

Anthracycline-induced cardiomyopathy in siblings with early breast cancer

Annals of oncology, 2011-07, Vol.22 (7), p.1692-1692

2011

Volltextzugriff (PDF)

Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study

British journal of cancer, 2004-06, Vol.90 (11), p.2131-2134

2004

Volltextzugriff (PDF)

Image‐guided biopsy in women with breast cancer presenting with peritoneal carcinomatosis

International journal of gynecological cancer, 2006-02, Vol.16 (S1), p.108-110

2006

Volltextzugriff (PDF)

Block sequential adriamycin CMF - optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?

British journal of cancer, 2002-12, Vol.87 (12), p.1365-1369

2002

Volltextzugriff (PDF)

Supradiaphragmatic manifestations of papillary serous adenocarcinoma of the ovary

Clinical radiology, 1999-11, Vol.54 (11), p.748-754

1999

Volltextzugriff (PDF)

Multiple myeloma treated with high dose intravenous melphalan

British journal of haematology, 1987-05, Vol.66 (1), p.55-62

1987

Volltextzugriff (PDF)

The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer

British journal of cancer, 1993-05, Vol.67 (5), p.1132-1135

1993

Volltextzugriff (PDF)

Chemotherapy for ovarian cancer - a consensus statement on standard practice

British journal of cancer, 1998-12, Vol.78 (11), p.1404-1406

1998

Volltextzugriff (PDF)

1 – 25 von 721

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(651)
Mit Volltextzugriff
(634)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Mucinous epithelial ovarian carcinoma

Clinical utility of complex multi-platform profiling in metastatic cancer patients

Feasibility and Compliance of Automated Measurement of Quality of Life in Oncology Practice

Women with peritoneal carcinomatosis of unknown origin: efficacy of image‐guided biopsy to determine site‐specific diagnosis

Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study

Vascular endothelial growth factor (VEGF) in breast cancer : Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial

Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: The ITS Study

Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies

Clinical outcomes according to age and comorbidities in the OSCAR UK observational study of front-line bevacizumab (BEV)-containing therapy for advanced ovarian cancer (aOC)

Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation

c-erbB-2 oncogene as a prognostic marker in breast cancer

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment

Detection of colorectal cancer cells in peripheral blood by reverse‐transcriptase polymerase chain reaction for cytokeratin 20

Peritoneal carcinomatosis: image-guided peritoneal core biopsy for tumor type and patient care

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

The acute phase protein response in patients receiving subcutaneous IL‐6

Anthracycline-induced cardiomyopathy in siblings with early breast cancer

Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study

Image‐guided biopsy in women with breast cancer presenting with peritoneal carcinomatosis

Block sequential adriamycin CMF - optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?

Supradiaphragmatic manifestations of papillary serous adenocarcinoma of the ovary

Multiple myeloma treated with high dose intravenous melphalan

The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer

Chemotherapy for ovarian cancer - a consensus statement on standard practice

Suchergebnisse filtern